These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35311112)

  • 21. Circulating Genetically Abnormal Cells Add Non-Invasive Diagnosis Value to Discriminate Lung Cancer in Patients With Pulmonary Nodules ≤10 mm.
    Ye M; Zheng X; Ye X; Zhang J; Huang C; Liu Z; Huang M; Fan X; Chen Y; Xiao B; Sun J; Bai C
    Front Oncol; 2021; 11():638223. PubMed ID: 33777797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial.
    Silvestri GA; Tanner NT; Kearney P; Vachani A; Massion PP; Porter A; Springmeyer SC; Fang KC; Midthun D; Mazzone PJ;
    Chest; 2018 Sep; 154(3):491-500. PubMed ID: 29496499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of a deep learning-based lung nodule detection system as an alternative reader in a Chinese lung cancer screening program.
    Cui X; Zheng S; Heuvelmans MA; Du Y; Sidorenkov G; Fan S; Li Y; Xie Y; Zhu Z; Dorrius MD; Zhao Y; Veldhuis RNJ; de Bock GH; Oudkerk M; van Ooijen PMA; Vliegenthart R; Ye Z
    Eur J Radiol; 2022 Jan; 146():110068. PubMed ID: 34871936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study.
    Walter JE; Heuvelmans MA; Bock GH; Yousaf-Khan U; Groen HJM; Aalst CMV; Nackaerts K; Ooijen PMAV; Koning HJ; Vliegenthart R; Oudkerk M
    Thorax; 2018 Aug; 73(8):741-747. PubMed ID: 29661918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A wavelet features derived radiomics nomogram for prediction of malignant and benign early-stage lung nodules.
    Jing R; Wang J; Li J; Wang X; Li B; Xue F; Shao G; Xue H
    Sci Rep; 2021 Nov; 11(1):22330. PubMed ID: 34785692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A simple assessment of lung nodule location for reduction in unnecessary invasive procedures.
    Kinsey CM; Billatos E; Mori V; Tonelli B; Cole BF; Duan F; Marques H; de la Bruere I; Onieva J; San José Estépar R; Cleveland A; Idelkope D; Stevenson C; Bates JHT; Aberle D; Spira A; Washko G; San José Estépar R
    J Thorac Dis; 2021 Jul; 13(7):4207-4216. PubMed ID: 34422349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung cancer prediction by Deep Learning to identify benign lung nodules.
    Heuvelmans MA; van Ooijen PMA; Ather S; Silva CF; Han D; Heussel CP; Hickes W; Kauczor HU; Novotny P; Peschl H; Rook M; Rubtsov R; von Stackelberg O; Tsakok MT; Arteta C; Declerck J; Kadir T; Pickup L; Gleeson F; Oudkerk M
    Lung Cancer; 2021 Apr; 154():1-4. PubMed ID: 33556604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of a Deep Learning Algorithm for the Detection of Malignant Pulmonary Nodules in Chest Radiographs.
    Yoo H; Kim KH; Singh R; Digumarthy SR; Kalra MK
    JAMA Netw Open; 2020 Sep; 3(9):e2017135. PubMed ID: 32970157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
    Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
    Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solitary pulmonary nodules: clinical prediction model versus physicians.
    Swensen SJ; Silverstein MD; Edell ES; Trastek VF; Aughenbaugh GL; Ilstrup DM; Schleck CD
    Mayo Clin Proc; 1999 Apr; 74(4):319-29. PubMed ID: 10221459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiological and pathological analysis of LDCT screen detected and surgically resected sub-centimetre lung nodules in 44 asymptomatic patients.
    Hu X; Zhao J; Qian H; Du G; Kelly M; Yang H
    Eur J Radiol Open; 2016; 3():223-9. PubMed ID: 27579337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Assisted Diagnosis System for Detection of Early Pulmonary Nodule in Computed Tomography Images.
    Liu JK; Jiang HY; Gao MD; He CG; Wang Y; Wang P; Ma H; Li Y
    J Med Syst; 2017 Feb; 41(2):30. PubMed ID: 28032305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive value of a novel Asian lung cancer screening nomogram based on artificial intelligence and epidemiological characteristics.
    Liu D; Sun X; Liu A; Li L; Li S; Li J; Liu X; Yang Y; Wu Z; Leng X; Wo Y; Huang Z; Su W; Du W; Yuan T; Jiao W
    Thorac Cancer; 2021 Dec; 12(23):3130-3140. PubMed ID: 34713592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules.
    Swensen SJ; Silverstein MD; Ilstrup DM; Schleck CD; Edell ES
    Arch Intern Med; 1997 Apr; 157(8):849-55. PubMed ID: 9129544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
    Li X; Zhang Q; Jin X; Cao L
    World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules.
    Daly S; Rinewalt D; Fhied C; Basu S; Mahon B; Liptay MJ; Hong E; Chmielewski G; Yoder MA; Shah PN; Edell ES; Maldonado F; Bungum AO; Borgia JA
    J Thorac Oncol; 2013 Jan; 8(1):31-6. PubMed ID: 23201823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction Model for Lung Cancer in High-Risk Nodules Being Considered for Resection: Development and Validation in a Chinese Population.
    Xia C; Liu M; Li X; Zhang H; Li X; Wu D; Ren D; Hua Y; Dong M; Liu H; Chen J
    Front Oncol; 2021; 11():700179. PubMed ID: 34631529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel high-resolution computed tomography-based radiomic classifier for screen-identified pulmonary nodules in the National Lung Screening Trial.
    Peikert T; Duan F; Rajagopalan S; Karwoski RA; Clay R; Robb RA; Qin Z; Sicks J; Bartholmai BJ; Maldonado F
    PLoS One; 2018; 13(5):e0196910. PubMed ID: 29758038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules.
    Xing L; Su J; Guarnera MA; Zhang H; Cai L; Zhou R; Stass SA; Jiang F
    Clin Cancer Res; 2015 Jan; 21(2):484-9. PubMed ID: 25593345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose computed tomography for lung cancer screening in Anhui, China: A randomized controlled trial.
    Rong F; Shi R; Hu L; Chen R; Wang D; Lv X; Zhao Y; Huang W; Yang Y; Zhou H; Hong K
    Front Oncol; 2022; 12():1059999. PubMed ID: 36591449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.